What alternative antidepressant can be given to a patient who experiences sexual dysfunction with Selective Serotonin Reuptake Inhibitor (SSRI) therapy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Alternative Antidepressants for Patients with SSRI-Induced Sexual Dysfunction

Bupropion is the most appropriate antidepressant choice for patients experiencing sexual dysfunction with SSRIs due to its significantly lower rates of sexual side effects while maintaining antidepressant efficacy.

Understanding Antidepressant-Related Sexual Dysfunction

Sexual dysfunction is a common side effect of many antidepressants, particularly SSRIs, affecting up to 63% of patients on second-generation antidepressants 1. These side effects often lead to medication non-adherence and can significantly impact quality of life.

Hierarchy of Sexual Side Effects Among Antidepressants

Antidepressants can be ranked by their risk of causing sexual dysfunction:

Antidepressant Risk Level
Paroxetine Highest risk
Sertraline, fluoxetine Moderate risk
Fluvoxamine, mirtazapine Lower risk
Bupropion Lowest risk

First-Line Alternative: Bupropion

Bupropion stands out as the optimal choice for patients experiencing SSRI-induced sexual dysfunction for several reasons:

  • It has the lowest risk of sexual side effects among commonly used antidepressants 1
  • In a double-blind comparison with sertraline, only 15% of men and 7% of women on bupropion developed sexual dysfunction, compared to 63% of men and 41% of women on sertraline 2
  • Sexual function improvements can be seen within the first two weeks of treatment at doses of 100-200 mg/day 3

Dosing and Administration

  • Start with bupropion SR 100 mg daily for 1 week
  • Increase to 100 mg twice daily if needed
  • May increase to maximum of 150 mg twice daily based on response
  • Monitor for improvement in both depressive symptoms and sexual function

Other Alternatives to Consider

Mirtazapine

  • Has lower rates of sexual dysfunction compared to SSRIs 1
  • May be particularly useful for patients with concurrent insomnia or appetite issues
  • Monitor for sedation and weight gain

Vortioxetine

  • Associated with lower rates of sexual dysfunction than SSRIs
  • May be considered when bupropion is contraindicated or ineffective

Important Clinical Considerations

Monitoring and Assessment

  • Actively assess sexual function before starting any antidepressant and at regular intervals during treatment
  • Evaluate all phases of sexual response (desire, arousal, orgasm)
  • Be aware that patients often underreport sexual side effects

Contraindications and Cautions

  • Bupropion is contraindicated in patients with seizure disorders, current or prior diagnosis of bulimia or anorexia nervosa
  • Use with caution in patients with a history of head trauma or central nervous system tumors
  • Bupropion may cause agitation, insomnia, or anxiety in some patients

Risk of Post-SSRI Sexual Dysfunction

  • Be aware that some patients may develop persistent sexual dysfunction that continues after SSRI discontinuation 4
  • This should be discussed when considering treatment options

When to Consider Specialist Referral

  • If sexual dysfunction persists despite switching to bupropion
  • If the patient has complex comorbidities requiring specialized management
  • If the patient has severe or treatment-resistant depression

By selecting bupropion as the alternative antidepressant for patients experiencing SSRI-induced sexual dysfunction, you can effectively manage both depression and minimize the impact on sexual function, potentially improving medication adherence and overall quality of life.

References

Guideline

Sexual Dysfunction and Antidepressant Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Antidepressant-induced sexual dysfunction.

The Medical journal of Australia, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.